The medical devices market is projected to grow at a CAGR of 7% from 2025 to 2030, driven by technological advancements, a ...

The AI in pharmacovigilance market is expected to grow at a CAGR of 12–15% from 2023 to 2030, driven by the need to automate ...

Overview of Breast Cancer Therapeutics MarketThe Global Breast Cancer Therapeutics Market is valued at USD 33.83 Billion in ...

The global operating room equipment market is set to witness a growth rate of 5% in the next 5 years. Technological ...

Market OutlineThe Global Weight Loss Drugs Market is valued at USD 2.88 Billion in 2024 and is projected to reach a value ...

Overview of Platelet Aggregation Devices MarketThe Global Platelet Aggregation Devices Market is valued at USD 590.65 Million ...

Overview of Hepatitis C Drug MarketThe global Hepatitis C Drug Market is valued at USD 7.95 Billion in 2024 and is projected ...

HAMBURG, DE / ACCESS Newswire / July 21, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces that it has updated its ...

The botulinum toxin market is projected to grow at a CAGR of approximately 10% from 2025 to 2030. This growth is driven by the increasing popularity of minimally invasive aesthetic treatments, the ...

Market is valued at USD 10.25 Billion in 2024 and is projected to reach a value of USD 610.1 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 45.00% between 2025 and 2035.Overview of ...

Change in ForecastEvotec adjusts revenue guidance and confirms profit guidance anticipating a more profitable revenue mix 21.07.2025 / 11:40 CET/CESTThe issuer is solely responsible for the content of ...

Market SynopsisThe Global Radiopharmaceuticals Market is valued at USD 6.8 Billion in 2024 and is projected to reach a value of USD 19.15 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of ...